Skip to main content
Premium Trial:

Request an Annual Quote

Waters, Thermo to Integrate UPLC and Mass Spec Products

NEW YORK, March 6 (GenomeWeb News) - Waters and Thermo Electron have entered into an agreement to integrate the Waters Acquity Ultra Performance Liquid Chromatography system with Thermo's line of mass spectrometers, the companies said today.

 

The agreement includes Thermo's Finnigan TSQ Quantum, LTQ Linear Ion Trap, LTQ FT Hybrid Linear Trap/Fourier Transform ICR and LTQ Orbitrap hybrid mass spectrometers.

 

The use of UPLC with mass spec is expected to increase throughput and performance, the companies said.

 

"UPLC peaks are narrower and sharper, signal-to-noise ratios are higher, and run times are shorter -- which are all key factors in enhancing the performance of virtually any mass spectrometer," said Rohit Khanna, vice president of worldwide marketing at Waters, in a statement.

 

Additional terms of the agreement were not provided.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.